Citation Impact
Citing Papers
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
2019
A viral assembly factor promotes AAV2 capsid formation in the nucleolus
2010
In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses
2008
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
Specification of SUMO1- and SUMO2-interacting Motifs
2006
Thermal Stability as a Determinant of AAV Serotype Identity
2017
Direct Head-to-Head Evaluation of Recombinant Adeno-associated Viral Vectors Manufactured in Human versus Insect Cells
2017
Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes
2017
Plk1-mediated Phosphorylation of Topors Regulates p53 Stability
2009
PIAS proteins: pleiotropic interactors associated with SUMO
2009
Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb
2000
AAV Capsid Structure and Cell Interactions
2011
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition
2010 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Current prospects for RNA interference-based therapies
2011
Intracellular transport of recombinant adeno-associated virus vectors
2012
Adeno-Associated Virus Is Associated with a Lower Risk of High-Grade Cervical Neoplasia
2001
The Human Intestinal Microbiome in Health and Disease
2016 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
p53 Ubiquitination: Mdm2 and Beyond
2006
Role of SUMO-Interacting Motif in Daxx SUMO Modification, Subnuclear Localization, and Repression of Sumoylated Transcription Factors
2006
Gut Commensal E. coli Proteins Activate Host Satiety Pathways following Nutrient-Induced Bacterial Growth
2015
Single-spike detection in vitro and in vivo with a genetic Ca2+ sensor
2008 StandoutNobel
Controlling and enhancing CRISPR systems
2020 StandoutNobel
Nanoparticle-mediated p53 gene therapy for tumor inhibition
2011
Safe harbours for the integration of new DNA in the human genome
2011
Atg8‐family interacting motif crucial for selective autophagy
2010 StandoutNobel
Gut microbiome and health: mechanistic insights
2022 Standout
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
2003
P-Glycoproteins and Multidrug Resistance
1996
Neuronal circuits that regulate feeding behavior and metabolism
2013
Functional Identification of Optimized RNAi Triggers Using a Massively Parallel Sensor Assay
2011
High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression
1997
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical Use
1999
Parkinson's disease
2015 Standout
AAV Hybrid Serotypes: Improved Vectors for Gene Delivery
2005
Improved efficacy of chemotherapy by parvovirus-mediated sensitisation of human tumour cells
1996
Parkinson's Disease: Gene Therapies
2012
Distinct Neuronal Coding Schemes in Memory Revealed by Selective Erasure of Fast Synchronous Synaptic Transmission
2012 StandoutNobel
Pc2-mediated Sumoylation of Smad-interacting Protein 1 Attenuates Transcriptional Repression of E-cadherin
2005
Scalable Downstream Strategies for Purification of Recombinant Adeno- Associated Virus Vectors in Light of the Properties
2015
Host-Microbe Interactions: Shaping the Evolution of the Plant Immune Response
2006 Standout
Adeno-Associated Virus Rep78 Inhibits Oncogenic Transformation of Primary Human Keratinocytes by a Human Papillomavirus Type 16-rasChimeric
1997
p53 in health and disease
2007 Standout
An amino-acid taste receptor
2002 StandoutNature
Regulation and Function of SUMO Modification
2004
Intrinsically disordered proteins in cellular signalling and regulation
2014 Standout
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
MYB transcription factors in Arabidopsis
2010 Standout
microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors
2010
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Posttranslational Modification of p53: Cooperative Integrators of Function
2009
SUMO on the road to neurodegeneration
2007
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
2016
Fluorogenic probes for live-cell imaging of the cytoskeleton
2014 StandoutNobel
Gene Transfer to the Nigrostriatal System by Hybrid Herpes Simplex Virus/Adeno-Associated Virus Amplicon Vectors
1999
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
2013 StandoutNobel
Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus
1996
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Ubc9 Sumoylation Regulates SUMO Target Discrimination
2008
Regulation of the sumoylation system in gene expression
2008
The p53 pathway: positive and negative feedback loops
2005 Standout
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
1999
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications
2017 StandoutNobel
Optogenetics in Neural Systems
2011 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
S/MAR Element Facilitates Episomal Long-Term Persistence of Adeno-Associated Virus Vector Genomes in Proliferating Cells
2017
Large-Scale Adeno-Associated Viral Vector Production Using a Herpesvirus-Based System Enables Manufacturing for Clinical Studies
2009
Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2
2002
Accurate Identification and Quantification of DNA Species by Next-Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells
2017
Topors Functions as an E3 Ubiquitin Ligase with Specific E2 Enzymes and Ubiquitinates p53
2004
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
The adeno-associated virus Rep78 major regulatory/transformation suppressor protein binds cellular Sp1 in vitro and evidence of a biological effect.
1996
Tumour stem cells and drug resistance
2005 Standout
Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants
2003
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector
1999
Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity
2002
Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus
2004
Human Adeno-Associated Virus Type 5 Is Only Distantly Related to Other Known Primate Helper-Dependent Parvoviruses
1999 StandoutNobel
Infectious Molecular Clones of Adeno-Associated Virus Isolated Directly from Human Tissues
2008
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Three-dimensional organization of promyelocytic leukemia nuclear bodies
2010 StandoutNobel
Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone
2003
Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions
2013
Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism
2000
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Adeno-Associated Virus Structural Biology as a Tool in Vector Development
2013
Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues
2005
Human Papillomavirus and Cervical Cancer
2003 Standout
RING Domain E3 Ubiquitin Ligases
2009 Standout
Functional Roles of Ubiquitin-Like Domain (ULD) and Ubiquitin-Binding Domain (UBD) Containing Proteins
2009
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes
2011
Improving the Quality of Adeno-Associated Viral Vector Preparations: The Challenge of Product-Related Impurities
2017
High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant
1995
Theranostics: Combining Imaging and Therapy
2011
Viral gene delivery vectors: the next generation medicines for immune-related diseases
2020
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
2016
Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2
1998
Emerging Targets in Photopharmacology
2016 StandoutNobel
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Adeno-Associated Virus Type 2 Capsids with Externalized VP1/VP2 Trafficking Domains Are Generated prior to Passage through the Cytoplasm and Are Maintained until Uncoating Occurs in the Nucleus
2006
Synthesis and in Vitro Multidrug Resistance Modulating Activity of a Series of Dihydrobenzopyrans and Tetrahydroquinolines
1999
Adeno-Associated Virus Major Rep78 Protein Disrupts Binding of TATA-Binding Protein to the p97 Promoter of Human Papillomavirus Type 16
2000
Resolving Adeno-Associated Viral Particle Diversity With Charge Detection Mass Spectrometry
2016
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
OneBac 2.0:Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA
2017
Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins
1997 StandoutNobel
Works of Stefan Weger being referenced
Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban
2006
Topors acts as a SUMO‐1 E3 ligase for p53 in vitro and in vivo
2005
Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction
2007
Integration Preferences of Wildtype AAV-2 for Consensus Rep-Binding Sites at Numerous Loci in the Human Genome
2010
Viral Vectors for Gene Transfer: Current Status of Gene Therapeutics
2009
An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy
2005
Arcuate NPY Controls Sympathetic Output and BAT Function via a Relay of Tyrosine Hydroxylase Neurons in the PVN
2013
The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo
2007
Mdr1P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood
1993
The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation
2003
OneBac: Platform for Scalable and High-Titer Production of Adeno-Associated Virus Serotype 1–12 Vectors for Gene Therapy
2013
OneBac 2.0: Sf 9 Cell Lines for Production of AAV5 Vectors with Enhanced Infectivity and Minimal Encapsidation of Foreign DNA
2015
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters
1995
Adeno-Associated Virus Type 2 Protein Interactions: Formation of Pre-Encapsidation Complexes
1999
Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins
1997
Packaging of Human Chromosome 19-Specific Adeno-Associated Virus (AAV) Integration Sites in AAV Virions during AAV Wild-Type and Recombinant AAV Vector Production
2003
Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins
1995
Antibody-Mediated Enhancement of Parvovirus B19 Uptake into Endothelial Cells Mediated by a Receptor for Complement Factor C1q
2014
Kinetics and Frequency of Adeno-Associated Virus Site-Specific Integration into Human Chromosome 19 Monitored by Quantitative Real-Time PCR
2002
Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression
2002
Subcellular compartmentalization of adeno-associated virus type 2 assembly
1997
Role of the Herpes Simplex Virus Helicase-Primase Complex during Adeno-Associated Virus DNA Replication
2006
Mdr1P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles
1990
The Adeno-Associated Virus Type 2 Regulatory Proteins Rep78 and Rep68 Interact with the Transcriptional Coactivator PC4
1999
High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence
2016